Form 4: iBio Director Gary Sender Acquires Shares in Open Market Transaction

Director Gary Sender purchased 9,191 shares of iBio, Inc. common stock at $2.72 per share on January 10, 2025.

Summary

• Gary Sender, a director at iBio, Inc., acquired 9,191 shares of the company's common stock.
• The purchase was made on January 10, 2025, at a price of $2.72 per share.
• The transaction was executed under a Securities Purchase Agreement with iBio, Inc.

Sentiment

Score: 6

Explanation: The document is a routine filing of an insider purchase, which is generally neutral to slightly positive as it can indicate confidence. However, it is not a major event.

Positives

• The purchase by a director may signal confidence in the company's future prospects.

Industry Context

This is a standard SEC Form 4 filing, which is common for corporate insiders who trade their company's stock. It provides transparency into insider transactions.

Comparison to Industry Standards

• Form 4 filings are a standard practice for publicly traded companies in the US, ensuring transparency of insider trading.
• The transaction is relatively small in terms of volume, which is common for individual director purchases.

Stakeholder Impact

• The purchase may have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

iBio, insider trading, Form 4, Gary Sender, share purchase, director, equity